TNXP
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Tonix Pharmaceuticals to present an analysis of Phase 3 TONMYA data at the IASP 2026 World Congress on PainOct 19, 2026
- Tonix Pharmaceuticals announces a second major managed Medicare payer agreement for TONMYASep 22, 2026
- Tonix Pharmaceuticals reported positive FDA Type C meeting minutes for the adaptive Phase 2 study of TNX-4800 to prevent Lyme diseaseAug 3, 2026
- Tonix Pharmaceuticals secured a major managed Medicare payer agreement for TONMYAJul 13, 2026
- Tonix Pharmaceuticals enrolled the first patient in the Phase 2 HORIZON study of TNX-102 SL for major depressive disorderJun 29, 2026